Easy Bio

Easy Bio Equity

The The Equity of Easy Bio (353810.KQ) as of Oct 23, 2026 is 107.19 B KRW. In the previous year, The Equity was 83.97 B KRW — a change of 27.65% (higher).

Equity

107.19 BKRW

YoY

27.65%

Last updated:

In 2025, Easy Bio's equity was 107.19 B KRW, a 27.65% increase from the 83.97 B KRW equity in the previous year.

The Easy Bio Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2020
34.04 B KRW
Jan 1, 2021
42.92 B KRW
Jan 1, 2022
49.96 B KRW
Jan 1, 2023
62.78 B KRW
Jan 1, 2024
83.97 B KRW
Jan 1, 2025
107.19 B KRW
The Easy Bio Equity history
YEAREquityYoY
107.19 BKRW+27.65%
83.97 BKRW+33.75%
62.78 BKRW+25.66%
49.96 BKRW+16.42%
42.92 BKRW+26.08%
34.04 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Easy Bio Stock analysis

What does Easy Bio do? Easy Bio Inc is a South Korean company based in Seoul, operating within the Consumer Staples sector, specifically in the Food Products industry. The company went public on June 5, 2020, and currently employs 126 people. Its primary business involves the production and distribution of animal feeds, including feed, feed ingredients, and animal feed additives. Easy Bio Inc markets its products both domestically within South Korea and internationally, with sales reaching markets such as the United States, Colombia, China, Vietnam, and Thailand. The company's headquarters are located in Seoul, South Korea, and it maintains a corporate website at http://www.easybio.co.kr/. The firm does not engage in any other business activities beyond the production and distribution of animal feeds and related products. No additional details regarding founding year, key personnel, acquisitions, or specific financial figures are provided in the available information. The company's operations are focused on serving the agricultural and livestock sectors through its feed solutions. Easy Bio is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Easy Bio's Equity

Easy Bio's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Easy Bio's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Easy Bio's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Easy Bio's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Easy Bio’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Easy Bio stock

The Equity of Easy Bio is 107.19 B KRW in 2025.

The Equity of Easy Bio changed from 83.97 B KRW to 107.19 B KRW, representing a 27.65% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Equity Easy Bio since 2006 – with annual values, charts, and detailed analysis.

The Equity's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Easy Bio historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Easy Bio

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Easy Bio